SkinBioTherapeutics, a life science company focused on skin health, announces that its wholly owned subsidiary, AxisBiotix Limited, has signed a development agreement with Winclove Probiotics B.V., (“Winclove”), a specialist in the research, development and manufacture of […]
DuPont Nutrition & Biosciences (DuPont) today announced a collaboration with the MRM Health NV (MRM Health), a biopharmaceutical company, focused on the discovery and development of innovative therapeutics based on the human microbiome. MRM Health […]
Da Volterra, a clinical-stage biopharmaceutical company developing innovative products to protect the intestinal microbiota from the damaging effects of antibiotics, today announced positive top-line results from a Phase 2 clinical trial ‘SHIELD’ evaluatingDAV132 in patients […]
Rebiotix, a Ferring company, announced today that it has completed enrollment of the pivotal Phase 3 clinical trial for RBX2660, an investigational therapy aimed at breaking the cycle of recurrent Clostridioides difficile (C. diff) infection, […]
TargEDys® announces the successful completion of its 3 months, randomized, double blind, placebo-controlled, multicentric clinical study carried out on 229 subjects and evaluating the efficacy of Hafnia alvei HA4597™ in the weight loss by regulation […]
MaaT Pharma announced today an €18 million Series B financing round including a microbiome-focused US investor, SymBiosis, LLC, and support from its existing investors Seventure Partners, Crédit Mutuel Innovation, and Biocodex. The funding will enable […]
Arranta Bio (“Arranta”), the leading microbiome contract development and manufacturing organization (CDMO), announced today the strengthening of its senior leadership team with the addition of David Stevens as Chief Operations Officer and Jason Rahal as […]
A new collaborative study published by a research team from the Wayne State University School of Medicine, the CReATe Fertility Centre and the University of Massachusetts Amherst provides the first in-depth look at the microbiome […]
A completely new kind of bioreactor for the biological production of methane has enabled the use of extremely high pressure levels for the first time – and set new efficiency standards for the conversion of […]
Kintai Therapeutics, a Flagship Pioneering company, today announced the advancement of KTX-0200, a novel oral anti-obesity agent, into IND-enabling studies following the demonstration of sustained weight loss and improved markers of health in preclinical studies. Treatment […]
Bloom Science, a biopharmaceutical company focused on the discovery and development of precision living medicines for currently untreatable neurological diseases, today announced signing of an agreement with Duke University, granting the Company an option to […]